A promising TB vaccine can be protected from heat damage with a technique developed at the University of Bath.
Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.
Their method prevents these crucial vaccine components from spoiling outside of a fridge – meaning a thermally stable vaccine that can be reliably delivered to remote areas around the world is more likely.
There is an urgent need not only for a new TB vaccine, but also for methods to keep vaccines stable outside of the refrigeration ‘cold chain’ – as up to 50% of vaccine doses are discarded before use due to exposure to suboptimal temperatures. Thermostable vaccines have therefore been named a priority research area in the World Health Organisation’s Global Vaccine Action Plan 2011-2020.
Ensilication, a method developed at the University of Bath, “shrink-wraps” vaccine proteins in position using layers of silica that build up into a cage around the molecules – so they don’t unravel when exposed to temperatures that would usually break them down. The proteins are held in place until ready to be removed from the silica cage and delivered.
The research team from the Departments of Biology & Biochemistry and Chemistry first demonstrated that the TB antigen ag85b and a vaccine fused with the adjuvant protein Sbi are sensitive to breaking down outside of refrigerated temperatures. They then showed that these vaccine components were protected from heat damage when ensilicated and kept on a shelf at room temperature for long periods of time without loss of structure and function.
This is first time that ensilication has been used to improve the thermal stability of proteins in a vaccine setting, after proof-of-principle work using model proteins.
The results are a big step forward not only in developing a thermally-stable TB vaccines, but in showing that ensilication could be used for many different kinds of vaccines.
The study is published in Scientific Reports
Lead author Professor Jean van den Elsen, said: “A new TB vaccine is really urgently needed to supplement or replace the existing BCG vaccine and reduce the number of TB cases and deaths – particularly as drug-resistant TB infections remain high.”
First author Ayla Wahid, added: “To make the vaccine as effective as possible it needs to be thermally-stable, or in other words not spoil outside of a fridge, which is why we’re really encouraged by these results. Cold-chain storage leads to a lot of wastage and expense which could be avoided by ensilication.”
Dr Asel Sartbaeva, who invented ensilication, added: “Our results reveal the potential of ensilication in storing and transporting life-saving vaccines at ambient temperatures globally – in particular to remote areas of developing countries where disease rates are often highest.
“With up to 50% of vaccines being thrown away, and refrigeration raising vaccine costs by up to 80%, this is a major global health challenge that we need to overcome. By demonstrating for the first time that ensilication works to protect vaccine-relevant proteins from breaking down outside a fridge we’re a big step closer to achieving this goal.”
The Latest on: TB vaccine
via Google News
The Latest on: TB vaccine
- What you need to know about pulmonary Tuberculosis on November 18, 2019 at 7:10 pm
... TB can be fatal and put other people at risk for getting sick. There is a vaccine available but is not widely used in the United States because it is not always effective at protecting adults. The ...
- Common TB vaccine associated with lower lung cancer rates on November 18, 2019 at 10:22 am
(HealthDay)—Childhood vaccination with the bacille Calmette-Guérin (BCG) vaccine is associated with a reduced risk for lung cancer, according to a study published online Sept. 25 in JAMA Network Open.
- New research into badger dispersal could minimize bovine tuberculosis spread on November 18, 2019 at 6:06 am
Their research, reported today, has major implications for implementing vaccination programs to limit the spread of bovine tuberculosis (TB). The findings come at an opportune time, as DAFM has ...
- BCG Tuberculosis (TB) Vaccine Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2025 on November 18, 2019 at 2:37 am
WiseGuyRerports.com Presents “Global BCG Tuberculosis (TB) Vaccine Market Size, Status and Forecast 2019-2025” New Document to its Studies Database The global BCG Tuberculosis (TB) Vaccine market, as ...
- TB Vaccines Market Analysis 2019-2026: Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory on November 17, 2019 at 9:05 pm
Nov 18, 2019 (Global QYResearch via COMTEX) -- Ameco Research presents "Global TB Vaccines 2019 Market Research Report" new Research to its studies database. According to the Ameco Research, the ...
- Pretoria still expecting BRICS to deliver vaccine research centre in South Africa on November 17, 2019 at 3:10 pm
The research centre is expected to focus on finding a vaccine for tuberculosis and the Brasilia Declaration did welcome the Collaborative Research Programme for TB, developed by BRICS TB Research ...
- New NIH funding will accelerate progress in TB vaccine development on November 17, 2019 at 5:50 am
Seattle Children's Research Institute is one of three recipients of $30 million in first-year-funding provided by the National Institute of Allergy and Infectious Diseases (NIAID), part of the ...
- CSU lands $1.2 million in NIH funding to advance work on a new tuberculosis vaccine on November 15, 2019 at 3:20 pm
Over the next seven years, CSU may be awarded up to $10.5 million to continue this work. New vaccines needed New and improved TB vaccines are badly needed. Over the past 200 years, tuberculosis has ...
- BCG Tuberculosis (TB) Vaccine Market is Booming Worldwide on November 14, 2019 at 12:48 am
Nov 14, 2019 (Market Prediction via COMTEX) -- The latest trending report Global BCG Tuberculosis (TB) Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2026 offered by ...
- We are gaining against TB but knowledge gaps remain on November 9, 2019 at 10:51 am
But this improvement is still not enough to achieve the United Nations’ goal of ending TB by 2030. Worldwide, TB remains the leading cause of death from a single infectious agent. Despite excellent ...
via Bing News